ACR Appropriateness Criteria® Ductal Carcinoma in Situ

Seth A. Kaufman, Eleanor E R Harris, Lisa Bailey, Manjeet Chadha, Sharon C. Dutton, Gary M. Freedman, Sharad Goyal, Michele Y. Halyard, Kathleen C. Horst, Kristina L M Novick, Catherine C. Park, W. Warren Suh, Deborah Toppmeyer, Jennifer Zook, Bruce G. Haffty

Research output: Contribution to journalArticlepeer-review


Ductal carcinoma in situ (DCIS) is a breast neoplasm with potential for progression to invasive cancer. Management commonly involves excision, radiotherapy, and hormonal therapy. Surgical assessment of regional lymph nodes is rarely indicated except in cases of microinvasion or mastectomy. Radiotherapy is employed for local control in breast conservation, although it may be omitted for select low-risk situations. Several radiotherapy techniques exist beyond standard whole-breast irradiation (ie, partial-breast irradiation [PBI], hypofractionated whole-breast radiation); evidence for these is evolving. We present an update of the American College of Radiology (ACR) Appropriateness Criteria® for the management of DCIS. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions, which are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi technique) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
JournalOncology (Williston Park, N.Y.)
Issue number6
StatePublished - Jun 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'ACR Appropriateness Criteria® Ductal Carcinoma in Situ'. Together they form a unique fingerprint.

Cite this